Latest News about GILD
Recent news which mentions GILD
Is There Any Hope for Atea Pharmaceuticals Stock?
November 04, 2021
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
From Benzinga
Healthcare Stocks Subject to Government Policy
November 02, 2021
From Benzinga
5 M&A Stocks to Watch as Goldman Calls for a Big Jump in Deals
November 01, 2021
From InvestorPlace
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Gilead Sciences (GILD) Q3 2021 Earnings Call Transcript
October 29, 2021
Tickers
GILD
From Motley Fool
CDC says people with mental health issues should get COVID-19 vaccine boosters, as U.S. vaccination rate remains stubbornly static
October 29, 2021
From MarketWatch
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
From Benzinga
Gilead Trims Non-COVID Product Sales Outlook, Though Q3 Earnings Beat Street Estimates
October 29, 2021
Tickers
GILD
From Benzinga
Gilead Sciences stock dips as results, outlook top Street view
October 28, 2021
Tickers
GILD
Tags
GILD
From MarketWatch
Pfizer Conceding Race in Hospitalized Covid Because of Todos Medical's Triple MOA Antiviral
October 28, 2021
From Benzinga
Fund managers are tossing out their losers. Here are the bargains investors might not want to miss.
October 28, 2021
From MarketWatch
2 Beaten-Down Biotech Stocks That Could Be Great Long-Term Plays
October 27, 2021
From Motley Fool
1 Small-Cap Stock With 10X Potential
October 27, 2021
From Motley Fool
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
From Benzinga
From Motley Fool
2 High-Yielding Stocks You Can Buy and Hold for Years
October 23, 2021
From Motley Fool
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
October 23, 2021
From Motley Fool
3 Under-the-Radar COVID Stocks
October 20, 2021
From Motley Fool
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
From Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
From Benzinga
From InvestorPlace
Why CRISPR Therapeutics Stock Is Sinking Today
October 13, 2021
From Motley Fool
Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means
October 12, 2021
From Benzinga
Moderna Stock Looks Fully Valued Here, But It Has a Great Future
October 08, 2021
From InvestorPlace
Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?
October 06, 2021
From Motley Fool
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
